文献速递消化道肿瘤放疗放疗物理与技术

局部胰腺癌等毒性高剂量SBRT后使用形变配准评估局部区域复发

Evaluation of loco-regional recurrences using deformable image registration after isotoxic high dose stereotactic body radiotherapy in localised pancreatic cancer.
PubMed 文献 · Clin Transl Radiat Oncol · 2025-11-19

本研究纳入2018年1月至2021年1月接受改良FOLFIRINOX化疗、等毒性高剂量立体定向体部放疗(iHD-SBRT)及可行手术的边界可切除/局部晚期胰腺腺癌患者,利用形变配准(DIR)将随访CT/MRI识别的局部区域复发(LRR)映射回初始放疗计划。41例中17例发现LRR,53%(n=9)为野外复发,边界复发位于肠系膜上动脉和腹腔干等大血管附近,提示计划时需扩大肿瘤-血管界面覆盖。

要点

  • iHD-SBRT后LRR以野外复发为主(53%,n=9),边界和野内复发各占23.5%(n=4)。
  • 边界复发多邻近肠系膜上动脉、腹腔干等腹部大血管。
  • 建议放疗计划中将肿瘤-血管界面(TVI)扩展至邻近血管全周并外放5 mm。

核心结论

  • 基于DIR的LRR分析强调应将TVI结构扩展至邻近血管全周并外放5 mm,未来治疗计划可能受益于扩大血管周围靶区覆盖。

研究设计与样本

  • 纳入2018年1月至2021年1月治疗的边界可切除/局部晚期胰腺腺癌患者,接受改良FOLFIRINOX化疗、iHD-SBRT及可行手术。
  • 随访CT/MRI识别的LRR通过验证的DIR工作流映射回初始放疗计划,并分类为野内、边界或野外复发。

主要发现

  • 41例患者中17例发现LRR(10例经CT,7例经MRI)。
  • LRR中野外复发占53%(n=9),野内和边界复发各占23.5%(n=4)。
  • 边界复发位于肠系膜上动脉和腹腔干等腹部大血管附近。
  • DIR质量指标DICE和MDA验证了映射过程的准确性。

关键数值与推荐

  • 建议将TVI结构扩展至邻近血管全周并外放5 mm。

临床怎么用

  • 对局部胰腺癌iHD-SBRT计划,应考虑将邻近大血管全周纳入TVI并外放5 mm以减少边界复发。
  • 可利用DIR工作流将随访影像复发映射回计划以评估复发模式并指导靶区优化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Pancreatic ductal adenocarcinoma is a highly aggressive malignancy with poor survival outcomes. Neoadjuvant treatments, including radiotherapy, have been developed to improve resectability and survival rates. This study evaluates loco-regional recurrence (LRR) patterns after isotoxic high-dose stereotactic body radiotherapy (iHD-SBRT) for localized pancreatic cancer using deformable image registration (DIR). MATERIALS AND METHODS: Patients with borderline/locally advanced pancreatic adenocarcinoma treated between January 2018 and January 2021 were included. Treatment involved modified FOLFIRINOX chemotherapy, iHD-SBRT, and surgery, if feasible. LRRs identified via CT/MRI during follow-up were mapped back onto initial radiotherapy planning using validated DIR workflows. Recurrences were classified as in-field (IF), marginal (M), or out-of-field (OF). RESULTS: Among 41 patients, LRRs were identified in 17 (10 via CT, 7 via MRI). The majority of LRRs were classified as OF (53 %, n = 9), with 23.5 % (n = 4) each in IF and M categories. Marginal recurrences were located near major abdominal vessels, such as the superior mesenteric artery and coeliac artery. DIR quality metrics, including DICE and MDA, validated the accuracy of the mapping process. CONCLUSION: Image based evaluation of loco-regional recurrence is an important part of the assessment of patients treated with iHD-SBRT for localised pancreatic cancer. DIR-based analysis emphasized the importance of expanding the tumor-vessel interface (TVI) structure in radiotherapy planning to include the full circumference of adjacent vessels with a 5 mm margin. DIR-based analysis highlighted that several marginal recurrences occurred in proximity to perivascular regions, suggesting a potential benefit of expanding perivascular target coverage in future treatment planning.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Manderlier M, Poeta S, Engelholm JL, et al. Evaluation of loco-regional recurrences using deformable image registration after isotoxic high dose stereotactic body radiotherapy in localised pancreatic cancer. Clin Transl Radiat Oncol. 2025. PMID: 41438099. doi:10.1016/j.ctro.2025.101081

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。